| Year |
Citation |
Score |
| 2014 |
On NH, Miller DW. Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier. Current Pharmaceutical Design. 20: 1499-509. PMID 23789953 DOI: 10.2174/13816128113199990458 |
0.349 |
|
| 2013 |
On NH, Savant S, Toews M, Miller DW. Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1944-54. PMID 24045401 DOI: 10.1038/jcbfm.2013.154 |
0.333 |
|
| 2013 |
On NH, Mitchell R, Savant SD, Bachmeier CJ, Hatch GM, Miller DW. Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model. Journal of Neuro-Oncology. 111: 133-43. PMID 23184143 DOI: 10.1007/s11060-012-1006-1 |
0.64 |
|
| 2011 |
Miller DW, Hinton M, Chen F. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers. Neurourology and Urodynamics. 30: 1633-8. PMID 21826715 DOI: 10.1002/nau.21110 |
0.389 |
|
| 2010 |
Chakravarthi SS, De S, Miller DW, Robinson DH. Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles. International Journal of Pharmaceutics. 383: 37-44. PMID 19747969 DOI: 10.1016/J.Ijpharm.2009.09.004 |
0.306 |
|
| 2010 |
Miller D, Chen F, Hinton M. 1502 INTERACTION OF DARIFENACIN WITH DRUG EFFLUX TRANSPORTERS: IMPLICATIONS IN THE BLOOD-BRAIN BARRIER PERMEABILITY OF THE DRUG Journal of Urology. 183. DOI: 10.1016/J.JURO.2010.02.1240 |
0.31 |
|
| 2007 |
Chavanpatil MD, Khdair A, Gerard B, Bachmeier C, Miller DW, Shekhar MP, Panyam J. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux. Molecular Pharmaceutics. 4: 730-8. PMID 17705442 DOI: 10.1021/Mp070024D |
0.637 |
|
| 2006 |
Bachmeier CJ, Trickler WJ, Miller DW. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 998-1003. PMID 16554372 DOI: 10.1124/dmd.105.006999 |
0.766 |
|
| 2005 |
McGuire TR, Trickler WJ, Smith L, Hoie EB, Miller DW. Release of TNF-alpha and IL-1beta from porcine brain endothelium corresponds to the pyrogenic potential of three marketed formulations of amphotericin. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 54: 375-9. PMID 16273336 DOI: 10.1007/s00011-005-1370-9 |
0.697 |
|
| 2005 |
Bachmeier CJ, Spitzenberger TJ, Elmquist WF, Miller DW. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier. Pharmaceutical Research. 22: 1259-68. PMID 16078135 DOI: 10.1007/s11095-005-5271-y |
0.677 |
|
| 2005 |
Haorah J, Heilman D, Knipe B, Chrastil J, Leibhart J, Ghorpade A, Miller DW, Persidsky Y. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcoholism, Clinical and Experimental Research. 29: 999-1009. PMID 15976526 DOI: 10.1097/01.Alc.0000166944.79914.0A |
0.369 |
|
| 2005 |
Trickler WJ, Mayhan WG, Miller DW. Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway. Brain Research. 1048: 24-31. PMID 15916752 DOI: 10.1016/j.brainres.2005.04.028 |
0.712 |
|
| 2005 |
De S, Miller DW, Robinson DH. Effect of particle size of nanospheres and microspheres on the cellular-association and cytotoxicity of paclitaxel in 4T1 cells. Pharmaceutical Research. 22: 766-75. PMID 15906172 DOI: 10.1007/S11095-005-2593-8 |
0.313 |
|
| 2005 |
Bachmeier CJ, Miller DW. A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier. Pharmaceutical Research. 22: 113-21. PMID 15771237 DOI: 10.1007/s11095-004-9016-0 |
0.702 |
|
| 2004 |
Batrakova EV, Zhang Y, Li Y, Li S, Vinogradov SV, Persidsky Y, Alakhov VY, Miller DW, Kabanov AV. Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier. Pharmaceutical Research. 21: 1993-2000. PMID 15587920 DOI: 10.1023/B:Pham.0000048189.79606.6E |
0.475 |
|
| 2004 |
Zhang Y, Schuetz JD, Elmquist WF, Miller DW. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. The Journal of Pharmacology and Experimental Therapeutics. 311: 449-55. PMID 15218051 DOI: 10.1124/Jpet.104.068528 |
0.43 |
|
| 2004 |
Bachmeier CJ, Trickler WJ, Miller DW. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF. Journal of Pharmaceutical Sciences. 93: 932-42. PMID 14999730 DOI: 10.1002/jps.20018 |
0.761 |
|
| 2003 |
Batrakova EV, Li S, Alakhov VY, Elmquist WF, Miller DW, Kabanov AV. Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharmaceutical Research. 20: 1581-90. PMID 14620511 DOI: 10.1023/A:1026179132599 |
0.387 |
|
| 2003 |
Trickler WJ, Miller DW. Use of osmotic agents in microdialysis studies to improve the recovery of macromolecules. Journal of Pharmaceutical Sciences. 92: 1419-27. PMID 12820146 DOI: 10.1002/jps.10410 |
0.702 |
|
| 2003 |
McGuire TR, Trickler WJ, Hock L, Vrana A, Hoie EB, Miller DW. Release of prostaglandin E-2 in bovine brain endothelial cells after exposure to three unique forms of the antifungal drug amphotericin-B: role of COX-2 in amphotericin-B induced fever. Life Sciences. 72: 2581-90. PMID 12672504 DOI: 10.1016/S0024-3205(03)00172-3 |
0.712 |
|
| 2003 |
Batrakova EV, Li S, Alakhov VY, Miller DW, Kabanov AV. Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. The Journal of Pharmacology and Experimental Therapeutics. 304: 845-54. PMID 12538842 DOI: 10.1124/Jpet.102.043307 |
0.452 |
|
| 2003 |
Kabanov AV, Batrakova EV, Miller DW. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Advanced Drug Delivery Reviews. 55: 151-64. PMID 12535579 DOI: 10.1016/S0169-409X(02)00176-X |
0.429 |
|
| 2003 |
Zhang Y, Bachmeier C, Miller DW. In vitro and in vivo models for assessing drug efflux transporter activity. Advanced Drug Delivery Reviews. 55: 31-51. PMID 12535573 DOI: 10.1016/S0169-409X(02)00170-9 |
0.683 |
|
| 2001 |
Sun H, Miller DW, Elmquist WF. Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models. Pharmaceutical Research. 18: 1542-9. PMID 11758761 DOI: 10.1023/A:1013074229576 |
0.423 |
|
| 2001 |
Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. British Journal of Cancer. 85: 1987-97. PMID 11747344 DOI: 10.1054/Bjoc.2001.2165 |
0.389 |
|
| 2001 |
Dash AK, Miller DW, Huai-Yan H, Carnazzo J, Stout JR. Evaluation of creatine transport using Caco-2 monolayers as an in vitro model for intestinal absorption. Journal of Pharmaceutical Sciences. 90: 1593-8. PMID 11745717 DOI: 10.1002/Jps.1109 |
0.39 |
|
| 2001 |
Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW, Kabanov AV. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. The Journal of Pharmacology and Experimental Therapeutics. 299: 483-93. PMID 11602658 |
0.318 |
|
| 2001 |
Sun H, Johnson DR, Finch RA, Sartorelli AC, Miller DW, Elmquist WF. Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice. Biochemical and Biophysical Research Communications. 284: 863-9. PMID 11409873 DOI: 10.1006/Bbrc.2001.5062 |
0.405 |
|
| 2001 |
Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. The Journal of Pharmacology and Experimental Therapeutics. 296: 551-7. PMID 11160643 |
0.328 |
|
| 2001 |
Sun H, Johnson DR, Finch RA, Sartorelli AC, Miller DW, Elmquist WF. Transport of Fluorescein in MDCKII-MRP1-Transfected Cells and mrp1-Knockout Mice Biochemical and Biophysical Research Communications. 286: 227. DOI: 10.1006/Bbrc.2001.5370 |
0.316 |
|
| 2000 |
Zhang Y, Han H, Elmquist WF, Miller DW. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Research. 876: 148-53. PMID 10973603 DOI: 10.1016/S0006-8993(00)02628-7 |
0.414 |
|
| 1999 |
Miller DW. Immunobiology of the blood-brain barrier. Journal of Neurovirology. 5: 570-8. PMID 10602398 DOI: 10.3109/13550289909021286 |
0.329 |
|
| 1999 |
Batrakova EV, Li S, Miller DW, Kabanov AV. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharmaceutical Research. 16: 1366-72. PMID 10496651 DOI: 10.1023/A:1018990706838 |
0.461 |
|
| 1999 |
Mark KS, Miller DW. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sciences. 64: 1941-53. PMID 10353592 DOI: 10.1016/S0024-3205(99)00139-3 |
0.721 |
|
| 1999 |
Miller DW, Batrakova EV, Kabanov AV. Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers. Pharmaceutical Research. 16: 396-401. PMID 10213370 DOI: 10.1023/A:1018873702411 |
0.387 |
|
| 1999 |
Miller DW, Kabanov AV. Potential applications of polymers in the delivery of drugs to the central nervous system Colloids and Surfaces B: Biointerfaces. 16: 321-330. DOI: 10.1016/S0927-7765(99)00082-X |
0.352 |
|
| 1998 |
Batrakova EV, Han HY, Miller DW, Kabanov AV. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharmaceutical Research. 15: 1525-32. PMID 9794493 DOI: 10.1023/A:1011942814300 |
0.456 |
|
| 1998 |
Batrakova EV, Han HY, Alakhov VYu, Miller DW, Kabanov AV. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharmaceutical Research. 15: 850-5. PMID 9647349 DOI: 10.1023/A:1011964213024 |
0.418 |
|
| 1998 |
Huai-Yun H, Secrest DT, Mark KS, Carney D, Brandquist C, Elmquist WF, Miller DW. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochemical and Biophysical Research Communications. 243: 816-20. PMID 9500978 DOI: 10.1006/Bbrc.1997.8132 |
0.764 |
|
| 1997 |
Miller DW, Batrakova EV, Waltner TO, Alakhov VYu, Kabanov AV. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjugate Chemistry. 8: 649-57. PMID 9327127 DOI: 10.1021/Bc970118D |
0.451 |
|
| 1996 |
Miller DW, Fontain M, Kolar C, Lawson T. The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Letters. 107: 301-6. PMID 8947528 DOI: 10.1016/0304-3835(96)04384-4 |
0.388 |
|
| 1996 |
Fontaine M, Elmquist WF, Miller DW. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sciences. 59: 1521-31. PMID 8890933 DOI: 10.1016/0024-3205(96)00483-3 |
0.435 |
|
| 1995 |
Wang Q, Yang H, Miller DW, Elmquist WF. Effect of the P-Glycoprotein Inhibitor, Cyclosporine A, on the Distribution of Rhodamine-123 to the Brain: An in Vivo Microdialysis Study in Freely Moving Rats Biochemical and Biophysical Research Communications. 211: 719-726. PMID 7598699 DOI: 10.1006/bbrc.1995.1872 |
0.337 |
|
| 1994 |
Miller DW, Keller BT, Borchardt RT. Identification and distribution of insulin receptors on cultured bovine brain microvessel endothelial cells: Possible function in insulin processing in the Blood-Brain barrier Journal of Cellular Physiology. 161: 333-341. PMID 7962117 DOI: 10.1002/Jcp.1041610218 |
0.393 |
|
| 1993 |
Tessel RE, Miller DW, Misse GA, Dong X, Doughty MB. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies. The Journal of Pharmacology and Experimental Therapeutics. 265: 172-7. PMID 8474004 |
0.573 |
|
| 1993 |
Tessel RE, Miller DW, Misse GA, Dong X, Doughty MB. Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure. Neuropeptides. 25: 289-98. PMID 7509465 DOI: 10.1016/0143-4179(93)90046-D |
0.576 |
|
| 1992 |
Miller DW, Audus KL, Borchardt RT. Application of cultured endothelial cells of the brain microvasculature in the study of the blood-brain barrier Journal of Tissue Culture Methods. 14: 217-224. DOI: 10.1007/Bf01409014 |
0.478 |
|
| 1991 |
Miller DW, Tessel RE. Age-dependent hyperresponsiveness of spontaneously hypertensive rats to the pressor effects of intravenous neuropeptide Y (NPY): role of mode of peptide administration and plasma NPY-like immunoreactivity. Journal of Cardiovascular Pharmacology. 18: 647-56. PMID 1723760 |
0.562 |
|
| 1990 |
Doughty MB, Chu SS, Miller DW, Li K, Tessel RE. Benextramine: a long-lasting neuropeptide Y receptor antagonist. European Journal of Pharmacology. 185: 113-4. PMID 1977597 DOI: 10.1016/0014-2999(90)90218-U |
0.535 |
|
| 1989 |
Miller DW, Yourick DL, Tessel RE. Antagonism of methoxyflurane-induced anesthesia in rats by benzodiazepine inverse agonists. European Journal of Pharmacology. 173: 1-10. PMID 2558027 DOI: 10.1016/0014-2999(89)90002-2 |
0.563 |
|
| Show low-probability matches. |